Cardiovascular and Obstetric Delivery Complications in Pregnant Women With Valvular Heart Disease

被引:7
作者
Minhas, Anum S. [1 ,2 ,6 ]
Rahman, Faisal [1 ,6 ]
Gavin, Nicole [3 ,6 ]
Cedars, Ari [1 ,6 ]
Vaught, Arthur Jason [3 ,6 ]
Zakaria, Sammy [1 ,6 ]
Resar, Jon [1 ,6 ]
Schena, Stefano [4 ,6 ]
Schulman, Steven [1 ,6 ]
Zhao, Di [5 ,6 ]
Hays, Allison G. [1 ,6 ]
Michos, Erin D. [1 ,6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Maternal Fetal Med, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Div Cardiac Surg, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Sch Med, Baltimore, MD USA
[6] Johns Hopkins Univ, Baltimore, MD USA
关键词
LOW-DOSE ASPIRIN; OUTCOMES;
D O I
10.1016/j.amjcard.2021.07.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Women with valvular heart disease may be more likely to have adverse obstetric and cardiovascular complications during pregnancy. Most current recommendations focus on stenotic lesions with less guidance regarding regurgitant lesions. We aimed to compare adverse events at delivery for women with various stenotic and regurgitant valvular diseases. We used the 2016 to 2018 National Inpatient Sample data to compare demographics, comorbidities, and obstetric and cardiovascular complications during delivery hospitalizations. After adjusting for clinical and socioeconomic factors, logistic regression was performed to investigate associations between valvular disease and outcomes. Among > 11.2 million deliveries, 20,349 were in women with valvular disease. Women with valvular disease were older, had longer length of stays, and higher costs associated with delivery. They had higher prevalence of underlying cardiovascular comorbidities compared with women without valvular disease (hypertension: 5.1 vs 0.25%; pulmonary hypertension: 7.0 vs < 0.1%). At delivery, they had higher adjusted odds of obstetric events including preeclampsia and/or eclampsia (aOR 1.9 [1.8 to 2.2]) and intrapartum/postpartum hemorrhage (aOR 1.4 [1.2 to 1.6]), and cardiovascular events including peripartum cardiomyopathy (aOR 65 [53 to 78]), pulmonary edema (aOR 17 [13 to 22]), acute ischemic heart disease (aOR 19 [12 to 30]) and arrhythmias (aOR 22 [19 to 27]). There were valve lesion-specific differences in the magnitude of risk but both stenotic and regurgitant lesions were associated with elevated risk of cardiovascular complications. In conclusion, pregnant women with stenotic and regurgitant valvular disease have a greater burden of cardiovascular comorbidities and increased odds of obstetric and cardiovascular events at delivery. These women may benefit from specialized care from a Cardio-Obstetrics team. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [41] Valvular Heart Disease in Pregnancy
    Bortnick, Anna E.
    Levine, Lisa D.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2020, 63 (04) : 910 - 922
  • [42] Haemorrhagic and thrombotic complications in pregnant women with acquired and congenital cardiac disease
    Kevane, Barry
    McKenna, Peter
    Walsh, Kevin
    Donnelly, Jennifer C.
    Flood, Karen
    Cullen, Michelle
    Bowen, Mary
    Thornton, Patrick
    Loughrey, John
    Coulter-Smith, Sam
    Ni Ainle, Fionnuala
    JOURNAL OF PERINATAL MEDICINE, 2015, 43 (02) : 165 - 169
  • [43] Valvular Heart Disease in Pregnancy
    Lewey, Jennifer
    Andrade, Lauren
    Levine, Lisa D.
    CARDIOLOGY CLINICS, 2021, 39 (01) : 151 - 161
  • [44] The Year in Valvular Heart Disease
    Rahimtoola, Shahbudin H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (12) : 1197 - 1207
  • [45] Maternal cardiac and obstetric performance in consecutive pregnancies in women with heart disease
    Gelson, E.
    Curry, R.
    Gatzoulis, M. A.
    Swan, L.
    Lupton, M.
    Steer, P. J.
    Johnson, M. R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (11) : 1552 - 1559
  • [46] The Year in Valvular Heart Disease
    Rahimtoola, Shahbudin H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (02) : 1 - 12
  • [47] Valvular heart disease in pregnancy
    Timmons, Paul
    Partridge, Gemma
    McKelvey, Alastair
    Lyall, Hamish
    Morosan, Monica
    Freeman, Leisa
    OBSTETRICIAN & GYNAECOLOGIST, 2023, 25 (01) : 19 - 27
  • [48] Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review
    Yaghoobpoor, Shirin
    Fathi, Mobina
    Vakili, Kimia
    Tutunchian, Zohreh
    Dehghani, Mina
    Bahrami, Ashkan
    Hajibeygi, Ramtin
    Eslami, Samira
    Yaghoobpour, Tina
    Hajiesmaeili, Mohammadreza
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [49] The Year in Valvular Heart Disease
    Rahimtoola, Shahbudin H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1290 - 1301
  • [50] Epidemiology of Valvular Heart Disease
    Peters, Alex S.
    Duggan, John P.
    Trachiotis, Gregory D.
    Antevil, Jared L.
    SURGICAL CLINICS OF NORTH AMERICA, 2022, 102 (03) : 517 - 528